Lv53
1330 积分 2025-11-05 加入
Exploring the role of G-quadruplex DNA, and their structural polymorphism, in targeting small molecules for the design of anticancer therapeutics: Progress, challenges, and future directions
13小时前
已完结
Bone and muscle crosstalk in ageing and disease
1天前
已完结
Agitation in schizophrenia: origins and evidence-based treatment
14天前
已完结
Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors
19天前
已关闭
Xanomeline, A Specific M1 Agonist: Early Clinical Studies
1个月前
已完结
Biomarker Utilization for Regulatory Decision Making: A Landscape Analysis of Neurological Drug Products Approved by FDA (2008–2024)
2个月前
已完结
Xanomeline: A Potent and Selective M1 Muscarinic Agonist in Vitro
2个月前
已完结
Shifting the trajectory of therapeutic development for neurological and psychiatric disorders
3个月前
已完结
The Safety and Tolerance of Xanomeline Tartrate, an M1-Specific Cholinergic Agonist, in Patients with Alzheimer’s Disease
4个月前
已完结
The PET tracer [ 11 C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer’s disease
4个月前
已完结
皖公网安备34019202002308
